VITAL: Vanguard Investigations of Therapeutic Approaches to Lung Cancer

Abstract

The VITAL Research Program will provide a better understanding of the cellular and molecular processes that drive lung tumorigenesis so that an accurate risk model can be developed. In addition, the clinical trials that will be conducted in the VITAL Research Program will demonstrate the true rate of lung cancer recurrence and second primary tumor incidence in patients at high risk for these events and will identify the combination of biologic agents most effective in reducing these events in the high-risk population. The primary objective of the work proposed in the VITAL Research Program is development of a risk model for development of cancer recurrence and smoking-related second primary tumors based on an understanding of the biology of lung cancer development.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2006
Accession Number
ADA469399

Entities

People

  • David M Stewart
  • Reuben Lotan
  • Waunki Hong

Organizations

  • The University of Texas MD Anderson Cancer Center

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Biological Factors
  • Biomedical Research
  • Cancer
  • Clinical Trials
  • Department Of Defense
  • Electronic Mail
  • Information Operations
  • Lung Cancer
  • Maryland
  • Neoplasms
  • Universities

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Military Science and Technology Research and Modernization.
  • Oncology (Cancer Research).